ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Merck KGaA has named Belén Garijo its CEO starting May 1, 2021. Garijo will become one of a handful of women leading major drug companies, including Emma Walmsley of GlaxoSmithKline, Deborah Dunsire at Lundbeck Pharmaceuticals, and Reshma Kewalramani of Vertex Pharmaceuticals. Currently deputy CEO, Garijo will succeed Stefan Oschmann. Garijo is a trained physician.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X